RACHEL PINK: Open Payments
NPI 1942940275 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,300 in 101 payments from 25 companies in 2025. Trend: 2023 $71 · 2024 $977 · 2025 $3,300
Food & beverage: $1,825Consulting: $1,200Education: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $1,230 |
| Astellas Pharma US Inc | 7 | $236 |
| SEAGEN INC. | 2 | $195 |
| Incyte Corporation | 8 | $177 |
| Daiichi Sankyo Inc. | 16 | $173 |
| SOBI, INC | 10 | $173 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| PFIZER INC. | 12 | $144 |
| Stemline Therapeutics Inc. | 6 | $133 |
| Merck Sharp & Dohme LLC | 4 | $100 |
Products named: Enhertu, Doptelet, JAKAFI, Orserdu, LIBTAYO, PADCEV, XTANDI, KEYTRUDA.
Industry payments across NV — which companies pay providers there.
